The test does not distinguish between antibodies to HIV-1
and HIV-2, and is not intended to be used for screening of blood donors.
An evaluation of dipstick-dot immunoassay in the detection of antibodies to HIV-1
and 2 in Zimbabwe.
Association of race and gender with HIV-1
RNA levels and immunologic progression.
Transmission of HIV-1
within a statewide prison system.
The FDA approves OraQuick Rapid HIV-1
Antibody Test, the first rapid test to use a finger prick.
Approved April 15, 1999 to treat HIV-1
in adults and children.
According to the Republic of China Ministry of Justice, the number of incarcerated drug offenders increased from 5,988 in 2003 to 9,303 in 2004; the rate of HIV-1
seropositive inmates increased from 13.
Even though HIV-2 replicates more slowly in the body than HIV-1
does, an HIV-2 infection can gradually provoke strong immune activation that appears to be just as damaging long-term as the immune activation triggered by HIV-1
, Grossman says.
antiretroviral therapy for children with perinatal HIV-1
infection," Journal of the American Medical Association, 284:190-7, July 12, 2000.
The FDA has NOT APPROVED these rapid HIV-1
home test kits being promoted on the Internet for use and marketing in the United States.
Nonhuman primates infected with SIV from the currently recognized lineages can harbor antibodies that serologically cross-react with some HIV-1
or HIV-2 antigens (3).
Our lab is interested in understanding how HIV-1
glycoprotein 120 (gp120) may activate intraeellular signals through these receptors in primary human macrophages, and how these responses may contribute to pathogenesis.